Chapter 16. Chemical Modification of Antibodies for Cancer Chemotherapy

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Annual Reports in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0065-7743(08)60844-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoclonal Antibodies: Principles and Practice

  1996cited by this paper
• Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice.

  1988cited by this paper
• Selective enhancement of antitumor activity of N-acetyl melphalan upon conjugation to monoclonal antibodies.

  1987cited by this paper
• Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.

  1987cited by this paper
• Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D.

  1987cited by this paper
• In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.

  1987cited by this paper
• Labeling of the oligosaccharide moieties of immunoglobulins.

  1987cited by this paper
• The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer

  1987cited by this paper
• Redesigning nature's poisons to create anti-tumor reagents.

  1987cited by this paper
• Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activation.

  1987cited by this paper
• Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model.

  1987cited by this paper
• Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.

  1987cited by this paper
• The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.

  1987cited by this paper
• Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.

  1987cited by this paper
• Comparative biodistribution of methotrexate and monoclonal antibody‐methotrexate complexes in mice

  1987cited by this paper
• Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats.

  1986cited by this paper
• Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

  1986cited by this paper
• An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines.

  1986cited by this paper
• Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside.

  1986cited by this paper
• Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.

  1986cited by this paper
• Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin.

  1986cited by this paper
• Specific immunosuppression by immunotoxins containing daunomycin.

  1986cited by this paper
• The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro.

  1986cited by this paper
• Specific targeting of chlorambucil to tumors with the use of monoclonal antibodies.

  1986cited by this paper
• Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.

  1986cited by this paper
• Antibody-Pseudomonas exotoxin A conjugates cytotoxic to human breast cancer cells in vitro.

  1986cited by this paper
• Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin.

  1986cited by this paper
• Conjugation behaviour of different monoclonal antibodies to f-methionyl-leucyl-phenylalanine.

  1986cited by this paper
• Prospects for immunotoxin therapy in cancer.

  1986cited by this paper
• Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin.

  1986cited by this paper
• Unsuitability of monoclonal antibodies to oncogene proteins for anti‐tumour drug‐targeting

  1986cited by this paper
• An Antibody‐Toxin Conjugate Directed against a Human Mammary Cancer Antigen a

  1986cited by this paper
• Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.

  1986cited by this paper
• Tumor location and drug targeting using a monoclonal antibody (anti‐SSEA‐1) and antigen‐binding fragments

  1986cited by this paper
• Modulation of anaphylatoxin desarginine complement c 5a induced biological reactions by platelet activating factor paf acether and structural analog

  1985cited by this paper
• The covalent linking of two nucleotide analogues to antibodies.

  1985cited by this paper
• Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.

  1985cited by this paper
• Studies on the mechanism of action of an antibody-targetted drug-carrier conjugate.

  1985cited by this paper
• Studies of methotrexate-monoclonal antibody conjugates for immunotherapy.

  1985cited by this paper
• Treatment of human colon adenocarcinoma heterografted into nude mice with anti-ceadaunorubicin conjugates

  1985cited by this paper
• Monoclonal antibodies for cancer detection and therapy

  1985cited by this paper
• Transferrin receptor as a target for antibody-drug conjugates.

  1985cited by this paper
• Monoclonal Antibodies: Their Chemistry, Functions, and Possible Uses

  1985cited by this paper
• Biological activities of human recombinant interferon α/β targeted by anti‐Epstein‐Barr virus monoclonal antibodies

  1985cited by this paper
• Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins.

  1985cited by this paper
• New heterobifunctional protein cross linking reagent that forms an acid labile link

  1985cited by this paper
• Linker Technology: Antibody-Mediated Delivery Systems

  1985cited by this paper
• Effect of methotrexate-albumin-monoclonal antibody conjugates on methotrexate-resistant cells

  1985cited by this paper
• An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.

  1985cited by this paper
• Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line.

  1985cited by this paper
• Antibodies as Carriers of Cancer Chemotherapeutic Agents a

  1985cited by this paper
• Production of a monoclonal antibody-mitomycin C conjugate, utilizing dextran T-40, and its biological activity.

  1985cited by this paper
• Characterization of translational inhibitors from Phytolacca americana. Amino-terminal sequence determination and antibody-inhibitor conjugates.

  1984cited by this paper
• Development and Use of Monoclonal Antibodies in the Treatment of Cancer

  1984cited by this paper
• Delivery of Ricin and Abrin A-Chains to Human Carcinoma Cells in Culture following Covalent Linkage to Monoclonal Antibody LICR-LOND-Fib 75

  1984cited by this paper
• A novel method of conjugation of daunomycin with antibody with a poly-L-glutamic acid derivative as intermediate drug carrier. An anti-alpha-fetoprotein antibody-daunomycin conjugate.

  1984cited by this paper
• Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediary.

  1984cited by this paper
• Production of a monoclonal antibody-methotrexate conjugate utilizing dextran T-40 and its biologic activity.

  1984cited by this paper
• Preparation of four daunomycin‐monoclonal antibody 79IT/36 conjugates with anti‐tumour activity

  1984cited by this paper
• Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.

  1984cited by this paper
• Chemotherapy with daunorubicin-anti-CEA conjugates in human colon adenocarcinoma grafted in nude mice.

  1984cited by this paper
• Monoclonal antibodies in the treatment of cancer.

  1984cited by this paper
• Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice.

  1984cited by this paper
• An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier.

  1984cited by this paper
• Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.

  1984cited by this paper
• Linkage of cytotoxic agents to immunoglobulins.

  1983cited by this paper
• Enhancement of macrophage invasion of tumors by administration of chemotactic factor-antitumor antibody conjugates.

  1983cited by this paper
• Targeting potential of antibody conjugates.

  1983cited by this paper
• Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitro

  1983cited by this paper
• Ricin B chain converts a non‐cytotoxic antibody‐ricin A chain conjugate into a potent and specific cytotoxic agent

  1983cited by this paper
• Production of a monoclonal antibody-bleomycin conjugate utilizing dextran T-40 and the antigen-targeting cytotoxicity of the conjugate.

  1983cited by this paper
• In Vitro and In Vivo Efficacy of Conjugates of Daunomycin with Anti‐Tumor Antibodies

  1982cited by this paper
• Platinum-complexed antitumor immunoglobulins that specifically inhibit DNA synthesis of mouse tumor cells.

  1982cited by this paper
• Covalent binding of methotrexate to immunoglobulins and the effect of antibody-linked drug on tumor growth in vivo.

  1981cited by this paper
• Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate.

  1981cited by this paper
• Targeting of drugs

  1977cited by this paper

• Recent Developments in Coumarin Derivatives for Breast Cancer Therapy

  2020cites this paper
• Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer

  2020cites this paper
• Implants in Drug Delivery

  2011cites this paper
• Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates.

  2007cites this paper
• Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide

  2005cites this paper
• Drug targeting by macromolecules without recognition unit?

  2003cites this paper
• Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals.

  2002cites this paper
• Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248)

  1997cites this paper
• Monoclonal antibodies in drug targeting

  1997cites this paper
• DRUG DESIGN : THE PRESENT AND THE FUTURE

  1995cites this paper
• Synthesis and evaluation of antibody-albumin-methotrexate ternary conjugates for cancer treatment.

  1994cites this paper
• Stereoselective synthesis of sugar-amino acid conjugates. A novel class of amino sugars☆

  1993cites this paper
• Chapter 25. New Approaches to Non-Immunogenic Monoclonal Antibody Cancer Therapies

  1993cites this paper
• The role of medicinal chemistry in the discovery of DNA-active anticancer drugs: from random searching, through lead development, to de novo design

  1992cites this paper
• Overview: Recent Developments in Anticancer Agents

  1991cites this paper
• Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.

  1990cites this paper
• Medicinal chemistry: a support or a driving force in drug research?

  1990cites this paper
• Drug Delivery Systems—2. Site‐Specific Drug Delivery Utilizing Monoclonal Antibodies

  1989cites this paper
• Chapter 23. Second Generation Recombinant Therapeutic Proteins

  1989cites this paper